L-selectin and skin damage in systemic sclerosis

James V Dunne1, Stephan F van Eeden, Kevin J Keen

  • 1Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. James.Dunne@VCH.ca

Plos One
|October 3, 2012
PubMed
Summary

Soluble L-selectin levels correlate with reduced skin damage in diffuse systemic sclerosis (dSSc) patients, suggesting it as a potential therapeutic target and outcome measure for dSSc.